home.aspx
 
EVENTS

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

Avrio Biopharmaceuticals

Avrio Biopharmaceuticals is dedicated to providing our clients with high quality, flexible and on time clinical trial material manufacturing services. Our experienced and dedicated staff and our world class facility allow us to provide our clients with timely solutions to meet the demand of early phase clinical trial material manufacturing.

RELATED NEWS


IU is employing these technologies to target certain cancers, such as multiple myeloma, triple-negative breast cancer, and pediatric sarcomas, and chronic diseases, such as diabetes and Alzheimer’s, explained Peter Embi, MD, president and CEO of Regenstrief Institute, which is a medical research organization affiliated with IU and Purdue University. IU decided to partner with LifeOmic, which provides a secure cloud service for the long-term storage, retrieval, analysis, and clinical use of...

READ MORE

Aberdeen announced Aberdeen Behavioral Technographics – the industry’s first install (technographic) data that actively measures technology in use. Legacy technographic data only provides a single yes/no estimate as to whether a company uses a specific technology. Aberdeen Behavioral Technographics is the first to measure technology usage down to company location, number of users and pains and priorities of the usage. In numerous tests, Aberdeen Behavioral Technographics has proven t...

READ MORE

CAMBRIDGE, Mass. & TOKYO--(BUSINESS WIRE)--Akebia Therapeutics, Inc. (NASDAQ: AKBA) and Otsuka Pharmaceutical Co., Ltd. today announced they have entered into a collaboration and license agreement in the U.S. for vadadustat, an oral hypoxia-inducible factor (HIF) stabilizer currently in development for the treatment of anemia associated with chronic kidney disease (CKD)...
BUSINESSWIRE.COM
READ MORE

Sermo’s drug-rating system by doctors for doctors is soaring. A little less than a year after its launch, the Yelp-like platform now has 655,000 ratings on more than 4,000 medications, CEO Peter Kirk tells us. More than half those drugs have at least 100 reviews and 18 of them have more than 1,000. For pharma companies, the database has come to serve as real-time feedback on physicans’ experiences with their particular drugs. It’s also a way to evaluate brand equity, check reac...
FIERCEPHARMA
READ MORE

At Leiden University in The Netherlands, research is being done on making vaccinations easier and more effective. Currently, needles are commonly used and no one, particularly children, is happy about that. Microneedles patches have been developed in the past, but while they’re effective in some applications, they suffer from many limitations. At Leiden University one approach is combining nanoparticles, that are encapsulating a vaccine, with microneedles. This will hopefully result in hig...

READ MORE

AstraZeneca’s Tagrisso has been awarded breakthrough status in the US as a first-line treatment for a specific type of non-small cell lung cancer (NSCLC), potentially speeding up its development and regulatory pathway....

READ MORE

EVENTS

SiriusDecisions 2019 Technology Exchange
SIRIUSDECISIONS 2019 TECHNOLOGY EXCHANGE
December 09-11, 2019
The drive for growth never ceases for b-to-b organizations, and more than ever technology is at the centre of enabling that progress. Gone are the days however when a disparate, disconnected set of platforms strewn across sales, marketing an product can serve the organization effectively. An aligned...

BIOFIT 2019
BIOFIT 2019
December 10-11, 2019
With the highest attending rate of academics, TTOs and research institutions, BioFIT is the place where academia-industry collaborations get started. BioFIT has taken on a whole new dimension becoming the meeting point in Europe for tech transfer and for sourcing early-stage innovations stemming fro...